Don't miss our weekly PhD newsletter | Sign up now Don't miss our weekly PhD newsletter | Sign up now

  DNA repair mechanism and inhibition of Tdp1


   School of Biological Sciences

This project is no longer listed on FindAPhD.com and may not be available.

Click here to search FindAPhD.com for PhD studentship opportunities
  Dr J Richardson, Dr H Interthal  No more applications being accepted  Competition Funded PhD Project (Students Worldwide)

About the Project

Interested individuals must follow Steps 1, 2 and 3 at this link on how to apply
http://www.ed.ac.uk/biology/prospective-students/postgraduate/pgr/how-to-apply

DNA topoisomerases have been described as “magicians of the DNA world”. They allow DNA strands and double helices to “pass through each other” thereby resolving topological strain created during DNA replication and transcription. To work their magic topoisomerases form a covalent complex with DNA. But if this complex is stalled, DNA damage ensues. This is the mode-of-action of the anti-cancer drug campothecin which intercalates at the topoisomerase IB (Topo IB)-DNA junction thereby stabilising the stalled nucleic acid-protein complex and ultimately leading to potentially lethal DNA double strand breaks.

However, the cell has a back-up plan: it can process stalled Topo IB-DNA complexes using the DNA repair enzyme tyrosyl-DNA phosphodiesterase 1 (Tdp1). Tdp1 hydrolyses the phosphodiester bond between a tyrosine side-chain on Topo IB and a DNA 3’ phosphate allowing the damaged DNA ends to be repaired. Blocking DNA repair by targeting human Tdp1 with small molecule inhibitors could be a useful adjunct to anti-cancer chemotherapy.

Our objectives are:
(1) To understand at the molecular level how human Tdp1 recognises, binds and processes its physiological Topo IB-DNA substrate. To address this we will use complementary structural and biochemical approaches.
(2) To identify small molecules that bind to and inhibit Tdp1. We will use both in silico and high-throughput in vitro approaches (beads coupled with chemical compounds). Potential inhibitors will be tested in vitro and in vivo in assays developed in the Interthal lab.
The student will develop a broad range of skills in structural biology and biochemistry (in the Richardson lab) and in the molecular biology of DNA repair (in the Interthal lab). Skills developed will include protein expression and purification; protein-DNA cleavage, binding and foot printing assays; structure determination by X-ray crystallography; fluorescence spectroscopy and high-throughput screening.

More information about the lab, our interests and publications can be found here: http://richardson.bio.ed.ac.uk/

Funding Notes

Please follow the instructions on how to apply http://www.ed.ac.uk/biology/prospective-students/postgraduate/pgr/how-to-apply

If you would like us to consider you for one of our scholarships you must apply by 12 noon on Monday 5th January 2018 at the latest.


References

Effects of DNA and protein size on substrate cleavage by human tyrosyl-DNA phosphodiesterase 1. Interthal, H. & Champoux, J. J. (2011) Biochemical Journal. 436, 3, p. 559-66

Identification of a putative Tdp1 inhibitor (CD00509) by in vitro and cell-based assays.
Dean RA, Fam HK, An J, Choi K, Shimizu Y, Jones SJ, Boerkoel CF, Interthal H, Pfeifer TA.
J Biomol Screen. (2014) Dec;19(10):1372-82.

SCAN1 mutant Tdp1 accumulates the enzyme--DNA intermediate and causes camptothecin hypersensitivity. Interthal H, Chen HJ, Kehl-Fie TE, Zotzmann J, Leppard JB, Champoux JJ.
EMBO J. 2005 Jun 15;24(12):2224-33.

How good is research at University of Edinburgh in Biological Sciences?


Research output data provided by the Research Excellence Framework (REF)

Click here to see the results for all UK universities

Where will I study?